Analyst Expectations for Silk Road Medical's Future
Portfolio Pulse from Benzinga Insights
Silk Road Medical (NASDAQ:SILK) has received mixed analyst ratings in the last quarter, with 4 bullish, 1 somewhat bullish, 1 indifferent, and 1 somewhat bearish. The average price target is $38.29, representing an upside from the current price of $18.6. However, this average is a 25.51% decrease from the previous average price target of $51.40.
September 06, 2023 | 1:00 pm
News sentiment analysis
Sort by:
Descending
NEUTRAL IMPACT
Mixed analyst ratings and a decreased average price target could lead to uncertainty for Silk Road Medical's stock.
The mixed analyst ratings indicate differing opinions on the company's performance, which could lead to uncertainty among investors. Additionally, the decrease in the average price target could be interpreted as a negative signal, potentially impacting the stock's short-term performance.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 100